Results 111 to 120 of about 40,760 (162)
, 2000 Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drugs, 1996
Ritonavir is a protease inhibitor with an HIV-1 resistance profile similar to that of indinavir, but different from that of saquinavir. Ritonavir has good oral bioavailability, and may increase the bioavailability of other protease inhibitors including saquinavir, nelfinavir, indinavir and VX-478.
A P, Lea, D, Faulds
+6 more sources
Ritonavir is a protease inhibitor with an HIV-1 resistance profile similar to that of indinavir, but different from that of saquinavir. Ritonavir has good oral bioavailability, and may increase the bioavailability of other protease inhibitors including saquinavir, nelfinavir, indinavir and VX-478.
A P, Lea, D, Faulds
+6 more sources
Journal of the Association of Nurses in AIDS Care, 2001
Treatment Review is intended to inform and update nurses about treatments relevant to HIV/AIDS. Product information presented in this column does not imply endorsement by the Association of Nurses in AIDS Care.
openaire +2 more sources
Treatment Review is intended to inform and update nurses about treatments relevant to HIV/AIDS. Product information presented in this column does not imply endorsement by the Association of Nurses in AIDS Care.
openaire +2 more sources
The Annals of Pharmacotherapy, 2002
OBJECTIVE: To review the pharmacology, virology, pharmacokinetics, efficacy, safety, and clinical use of lopinavir/ritonavir (Kaletra, Abbott Laboratories). DATA SOURCES: English-language MEDLINE and AIDSline searches were performed (1966–July 2001) using lopinavir, ABT-378, and Kaletra as key words.
Amanda H, Corbett +2 more
openaire +2 more sources
OBJECTIVE: To review the pharmacology, virology, pharmacokinetics, efficacy, safety, and clinical use of lopinavir/ritonavir (Kaletra, Abbott Laboratories). DATA SOURCES: English-language MEDLINE and AIDSline searches were performed (1966–July 2001) using lopinavir, ABT-378, and Kaletra as key words.
Amanda H, Corbett +2 more
openaire +2 more sources